Many of the neuroprotective, neurodegenerative, psychiatric, and addiction-related applications discussed remain investigational, and no GLP-1 receptor agonist is currently approved by regulatory authorities for the treatment or prevention of Alzheimers disease, Parkinsons disease, depression, substance use disorders, or other neurological indications unless specifically stated otherwise
Whether macronutrient ratios, micronutrient concentrations, or bioactive factors in milk change during maternal GLP-1 therapy is an open question
LPV/r, lopinavir and ritonavir
Tirzepatide can also help with weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced-calorie diet and increased physical activity
Let's get into the specifics